{"abuse":["Abuse"],"adverse_reactions":["ADVERSE REACTIONS Adverse reactions have been reported with specific vitamins and minerals, but generally at levels substantially higher than those in STROVITE ® ONE. However, allergic and idiosyncratic reactions are possible at lower levels."],"carcinogenesis_and_mutagenesis_and_impairment_of_fertility":["Carcinogenesis, Mutagenesis, Impairment of Fertility"],"clinical_pharmacology":["CLINICAL PHARMACOLOGY"],"contraindications":["CONTRAINDICATIONS STROVITE ® ONE is contraindicated in patients with hypersensitivity to any of its components. Not intended for treatment of pernicious anemia or other megaloblastic anemias where vitamin B12 is deficient. Neurologic involvement may develop or progress, despite temporary remission of anemia, in patients with vitamin B12 deficiency who receive supplemental folic acid and who are inadequately treated with B12. Vitamin D supplementation should be introduced with caution in those with rare parathyroid, calcium metabolism, and correlated secondary disorders. In addition, concurrent introduction of vitamin D with medications such as digoxin and thiazide diuretics should proceed with caution secondary to vitamin D's possible effect on serum calcium levels."],"controlled_substance":["Controlled Substance"],"dependence":["Dependence"],"description":["DESCRIPTION STROVITE ® ONE is a prescription-only multivitamin/mineral caplet specially formulated for prophylactic or therapeutic nutritional supplementation in physiologically stressful conditions. STROVITE ® ONE supplies therapeutic levels of water soluble vitamins (ascorbic acid, folic acid, vitamins: B1, B6, B12); supplemental levels of vitamin B2, niacin, biotin, pantothenic acid, fat soluble nutrients, mixed carotenoids, vitamins E and D. Minerals (chromium, magnesium, manganese, selenium, zinc, copper). Also contained in STROVITE ® ONE are the nutrients alpha-lipoic acid and lutein. Recent medical reports have shown a causal effect regarding the use of folic acid and the lowering of elevated levels of homocysteine. Elevated homocysteine levels have been identified as one of the risk factors for heart attacks and strokes in men."],"dosage_and_administration":["DOSAGE AND ADMINISTRATION Usual adult dosage; one tablet daily, or as directed by a physician."],"drug_abuse_and_dependence":["DRUG ABUSE AND DEPENDENCE Controlled Substance Abuse Dependence"],"drug_and_or_laboratory_test_interactions":["Drug/Laboratory Test Interactions"],"drug_interactions":["Interactions Drug Interactions As little as 5 mg of Pyridoxine daily can decrease the efficacy of Levodopa in the treatment of Parkinsonism. Therefore, STROVITE ® ONE is not recommended for patients undergoing such therapy. Drug/Laboratory Test Interactions","Drug Interactions As little as 5 mg of Pyridoxine daily can decrease the efficacy of Levodopa in the treatment of Parkinsonism. Therefore, STROVITE ® ONE is not recommended for patients undergoing such therapy."],"effective_time":"20110323","general_precautions":["General"],"geriatric_use":["Geriatric Use"],"how_supplied":["HOW SUPPLIED STROVITE ® ONE is a white, oblong caplet, embossed “EV 0207”; available in bottles of 90s. NDC # 0642-0207-90. Store at controlled room temperature, 15°-30°C (59°-86°F). Avoid excessive heat. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Store at controlled room temperature 15°-30°C (59°-86°F). Protect from light and moisture and avoid excessive heat. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN"],"id":"89d74cbf-b6c8-44ae-80c7-2668ffeb00aa","indications_and_usage":["INDICATIONS AND USAGE STROVITE ® ONE is indicated for prophylactic or therapeutic conditions. These include: Conditions causing depletion, or reduced absorption or bioavailability of essential vitamins and minerals. Inadequate intake due to highly restricted or unbalanced diets such as those frequently associated with anorexic conditions and other states of severe malnutrition. Gastrointestinal disorders, chronic alcoholism, chronic or acute infections (especially those involving febrile illness), prolonged or wasting disease, congestive heart failure, hyperthyroidism, poorly controlled diabetes or other physiologic stress. Also patients on estrogenic oral contraceptives or other estrogen therapy, antibacterials which affect intestinal microflora, or other interfering drugs. Certain conditions resulting from severe B-vitamin or ascorbic acid deficiency. Cheilosis, gingivitis, stomatitis and certain other classic water-soluble vitamin deficiency syndromes. Conditions resulting in increased needs for essential vitamins and minerals. Recovery from surgery or trauma involving severe burns, fractures or other extensive tissue damage. In addition, pregnant women and those with heavy menstrual bleeding. Vitamin D supplementation may be beneficial to those who are institutionalized and/or have reduced exposure to sunlight. STROVITE ® ONE is a prescription-only multivitamin/mineral caplet specially formulated for prophylactic or therapeutic nutritional supplementation in physiologically stressful conditions."],"information_for_patients":["Information for Patients"],"labor_and_delivery":["Labor and Delivery"],"laboratory_tests":["Laboratory Tests"],"nonteratogenic_effects":["Nonteratogenic Effects"],"nursing_mothers":["Nursing Mothers"],"openfda":{},"overdosage":["OVERDOSAGE"],"package_label_principal_display_panel":["PACKAGE/LABEL PRINCIPAL DISPLAY PANEL CONTAINER LABEL 7123 CL"],"pediatric_use":["Pediatric Use"],"precautions":["PRECAUTIONS General Information for Patients Laboratory Tests Interactions Drug Interactions As little as 5 mg of Pyridoxine daily can decrease the efficacy of Levodopa in the treatment of Parkinsonism. Therefore, STROVITE ® ONE is not recommended for patients undergoing such therapy. Drug/Laboratory Test Interactions Carcinogenesis, Mutagenesis, Impairment of Fertility Pregnancy Teratogenic Effects Nonteratogenic Effects Labor and Delivery Nursing Mothers Pediatric Use Geriatric Use"],"pregnancy":["Pregnancy Teratogenic Effects Nonteratogenic Effects"],"set_id":"89d74cbf-b6c8-44ae-80c7-2668ffeb00aa","spl_product_data_elements":["STROVITE ONE OIL AND WATER SOLUBLE VITAMINS AND MINERALS FOLIC ACID FOLIC ACID THIAMINE HYDROCHLORIDE THIAMINE RIBOFLAVIN RIBOFLAVIN CYANOCOBALAMIN CO-57 CYANOCOBALAMIN CO-57 BIOTIN BIOTIN CHOLECALCIFEROL CHOLECALCIFEROL NIACINAMIDE NIACINAMIDE PYRIDOXINE HYDROCHLORIDE PYRIDOXINE PANTOTHENIC ACID CALCIUM PANTOTHENATE ZINC OXIDE ZINC OXIDE CUPRIC SULFATE COPPER CHROMIC CHLORIDE CR-51 CHROMIUM CR-51 SODIUM SELENITE SELENIUM MANGANESE SULFATE MANGANESE MAGNESIUM OXIDE MAGNESIUM VITAMIN A VITAMIN A .ALPHA.-TOCOPHEROL SUCCINATE, D- ALPHA-TOCOPHEROL ASCORBIC ACID ASCORBIC ACID ALPHA LIPOIC ACID ALPHA LIPOIC ACID LUTEIN LUTEIN DIBASIC CALCIUM PHOSPHATE DIHYDRATE SILICON DIOXIDE CELLULOSE, MICROCRYSTALLINE STEARIC ACID CROSCARMELLOSE SODIUM MAGNESIUM STEARATE EV;0207"],"teratogenic_effects":["Teratogenic Effects"],"version":"1","warnings":["WARNINGS"]}